Author

Irina A. Karputs

Observed names: A.Yu. Karputs, I. A. Karput, I. A. Karputs, I.A. Karputs, Karputs Irina A.

Institution: Grodno State Medical University

Observed institutions: National Academy of Sciences of Belarus, Grodno State Medical University, Institute of Bioorganic Chemistry

ORCID: 0000-0003-0478-9419

Observed ORCID: 0000-0003-0478-9419

OpenAlex ID: A5024158330

Molecular genetic indicators of the probability of early myocardial systolic dysfunction signs in doxorubicin chemotherapy in patients with breast cancer of moderate and low HFA-ICOS risk groups

2024 · I. A. Karput, V. A. Snezhitsky, et al. · Russian Journal of Cardiology · 3

Role of the Ttn, Ttn-truncation, Mmp-2 and Mmp-3 Genes Polymorphisms in the Development of Anthracyclineinduced Cardiomyopathy

2021 · I. A. Karputs, V. A. Snezhitskiy, et al. · Journal of the Grodno State Medical University · 3

Связь Уровней Лабораторных Показателей Сердечного Поражения И Металлопротеиназ С Развитием Антрациклин-индуцированной Кардиотоксичности У Пациентов Со Злокачественными Новообразованиями Молочной Железы Через 12 Месяцев После Окончания Химиотерапии

2024 · Karputs Irina A., Snezhitskiy Victor A., et al. · Emergency Cardiology and Cardiovascular Risks · 2

Biosensor selection of small compounds, modulating a complex formation between cytochrome P450s and NADPH-dependent P450 oxidoreductase

2020 · P.V. Ershov, E.O. Yablokov, et al. · Biomedical Chemistry Research and Methods · 1

Differential Genetic and Morphofunctional Patterns of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients with Pre-existing Hypertension

2026 · Irina A. Karputs, Victor A. Snezhitskiy, et al. · Research Square

Changes in Electrocardiographic Indicators of Depolarization and Repolarization During Chemotherapy of Breast Cancer With Doxorubicin

2024 · I. A. Karputs, V. A. Snezhitskiy, et al. · Journal of the Grodno State Medical University

Rare Variants of the Ttn Gene in Breast Cancer Patients With Moderate and Low Cardiovascular Risk (hfa-icos) During Chemotherapy With Doxorubicin

2024 · Irina A. Karputs · Vestnik of Vitebsk State Medical University

Use of indicators of systolic and diastolic functions of the left ventricle in the diagnosis of early cardiotoxicity during chemotherapy with doxorubicin: An open, prospective, nonrandomized study

2024 · Irina A. Karputs, Victor A. Snezhitskiy, et al. · Cardiosomatics

The Potential of Using the Dynamics of Electrocardiographic Parameters in Detecting Cardiotoxicity 12 Months After the End of Chemotherapy for Breast Cancer With Doxorubicin

2024 · I. A. Karputs, V. A. Snezhitskiy, et al. · Journal of the Grodno State Medical University

Molecular-genetic predictors of cardiotoxicity 12 months after the end of chemotherapy with doxorubicin in patients with breast cancer

2024 · I.A. Karputs, V.A. Snezhitskiy, et al. · Clinica Chimica Acta

Plasma levels of matrix metalloproteinases in patients with breast cancer as a potential marker of cardiotoxicity associated with doxorubicin therapy

2024 · I.A. Karputs, V.A. Snezhitskiy, et al. · Clinica Chimica Acta

Opportunities of using DNA nanosensors for monitoring hepatitis E virus RNA in infectious hospitals

2024 · A.S. Babenka, S.V. Zhavoronok, et al. · Clinica Chimica Acta

Works count: 12

Citation count: 9

H-index: 2

I10-index: